ArticleRoyal Society open science2025
Molecular flexibility of hyaluronic acid has a profound effect on invasion of cancer cells.
Article in Royal Society open science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Beyond the Monolayer: Leveraging 3D Culture Systems to Decode Mechanisms of Drug Resistance and Therapeutic Vulnerabilities in Colorectal Cancer.Cancer medicine · 2026Review
- Anomalous Diffusion of Nanoparticles in Semidilute Hyaluronic Acid Solutions.Biomacromolecules · 2026Article
- Preserving integrity: innovative in vitro methods for extracellular matrix decellularization and collagen purification.Journal of biological engineering · 2026Article
- Molecular flexibility of hyaluronic acid has a profound effect on invasion of cancer cells.Royal Society open science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular hyaluronic acid (HA) has been shown to be important in cancer; low-molecular-weight HA typically correlates with cancer progression, high-molecular-weight HA with homeostasis. Here we show that even high-molecular-weight HA can induce cancer cell migration when it is highly diluted. HA-induced cell signalling is primarily through HA binding to the cell surface receptor, CD44. We show by NMR spectroscopy that at high dilution, high-molecular-weight HA molecules access the conformations needed for strong binding to CD44 on the tens of nanosecond time scale, the relevant time scale for induction of CD44 signalling. We further show that, by contrast, at higher concentrations, high-molecular-weight HA molecules have insufficient flexibility for strong CD44 binding. The high dilution HA condition correlates with profound changes in brain cancer cell morphology and proteome which supports cancer cell invasion. We hypothesize that the flexibility of HA molecules is central to HA-mediated cell signalling and that this concept can explain previous observations that the outcome of HA-mediated signalling depends on the HA molecular weight. HA dilution leading to stronger HA signalling may be important in understanding the role that oedema plays in cancer recurrence after primary surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.